ASO Author Reflections: Who Benefits From Adjuvant PD-1 Inhibition? Navigating Time-Dependent Efficacy in Resected HCC.
Saved in:
| Title: | ASO Author Reflections: Who Benefits From Adjuvant PD-1 Inhibition? Navigating Time-Dependent Efficacy in Resected HCC. |
|---|---|
| Authors: | Guo B; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Luo C; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhang W; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wgzhang@tjh.tjmu.edu.cn. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2026 Feb; Vol. 33 (2), pp. 1552-1553. Date of Electronic Publication: 2025 Oct 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1534-4681 |
|---|---|
| DOI: | 10.1245/s10434-025-18654-2 |
